miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1

Myotonic dystrophy type 1 (DM1) is the most common adult-onset muscular dystrophy, primarily characterized by muscle wasting and weakness. Many biomarkers already exist in the rapidly developing biomarker research field that aim to improve patients’ care. Limited work, however, has been performed on...

Descripción completa

Detalles Bibliográficos
Autores principales: Koutalianos, Demetris, Koutsoulidou, Andrie, Mytidou, Chrystalla, Kakouri, Andrea C., Oulas, Anastasis, Tomazou, Marios, Kyriakides, Tassos C., Prokopi, Marianna, Kapnisis, Konstantinos, Nikolenko, Nikoletta, Turner, Chris, Lusakowska, Anna, Janiszewska, Katarzyna, Papadimas, George K., Papadopoulos, Constantinos, Kararizou, Evangelia, Spyrou, George M., Gourdon, Geneviève, Zamba Papanicolaou, Eleni, Gorman, Grainne, Anayiotos, Andreas, Lochmüller, Hanns, Phylactou, Leonidas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517008/
https://www.ncbi.nlm.nih.gov/pubmed/34703840
http://dx.doi.org/10.1016/j.omtm.2021.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517008/
https://www.ncbi.nlm.nih.gov/pubmed/34703840
http://dx.doi.org/10.1016/j.omtm.2021.09.007

Ejemplares similares